EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Short- and Long-Term Outcomes after Radiofrequency Ablation of Osteoid Osteomas

Thomas J Vogl iD, Michael Bialek, Katrin Eichler, Renate Hammerstingl, John Bielfeldt iD, Stephan Zangos, Jan-Erik Scholtz, Hamzah Adwan iD

Journal of Personalized Medicine · 10.04.2024 · 14 (4) · 401

DOI: 10.3390/jpm14040401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 10.04.2024. Verfasst von Thomas J Vogl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Radiology and Nuclear Medicine, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to evaluate treatment of osteoid osteomas using bipolar radiofrequency ablation (RFA) and patients’ quality of life before and after therapy. We retrospectively evaluated patients who underwent bipolar RFA of osteoid osteomas between 2001 and 2016. We assessed patients’ symptoms before and after treatment (four weeks after treatment and long-term) using a questionnaire including severity and quality of pain on a 10-point scale (1 = no pain, 10 = severe pain), motion restrictions, pain-related sleep disorders, and necessary pain medication. In addition, we evaluated technical success, complications, hospitalization length, and patients’ satisfaction with treatment. This study included 62 patients (43 [69.4%] males, 26.2 ± 13.2 years). Average nidus size was 5.7 ± 2.6 mm. The rate of technical success was 100%. All RFAs were performed without any complications. One patient showed a recurrence, resulting in a recurrence rate of 1.6%, which was successfully treated by another session of RFA. Average hospitalization length was 1.5 ± 0.5 days. A total of 36 patients (58.1%) participated in the questionnaire, reporting an average pain severity of 8.2 ± 1.6 before RFA compared to 3.4 ± 3.0 four weeks after and an average of 2.1 ± 2.3, 6.6 years after therapy, (both p < 0.001). After therapy, 31 (86.1%) patients had no pain. The majority of patients (n = 34, 94.4%) had reduced or absent motion restriction after therapy (p < 0.001). Patient satisfaction rate was 91.7%. In conclusion, bipolar RFA is a safe and effective treatment modality for osteoid osteomas and improves quality of life by reducing pain severity and motion restrictions.

Schlagwörter

Stichwörter der Autor:innen

bone tumorcomplicationslife qualityosteoid osteomapainpercutaneous radiofrequency ablationthermal ablation

Autor:innen und Institutionen

  • Clinic for Radiology and Nuclear Medicine, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.

ORCID-Profile: Thomas J Vogl, John Bielfeldt, Hamzah Adwan

Zitieren

APA

Vogl, T. J., Bialek, M., Eichler, K., Hammerstingl, R., Bielfeldt, J., Zangos, S., Scholtz, J. E., & Adwan, H. (2024). Short- and Long-Term Outcomes after Radiofrequency Ablation of Osteoid Osteomas. Journal of Personalized Medicine, 14(4), 401. https://doi.org/10.3390/jpm14040401

Vancouver

Vogl TJ, Bialek M, Eichler K, Hammerstingl R, Bielfeldt J, Zangos S, et al. Short- and Long-Term Outcomes after Radiofrequency Ablation of Osteoid Osteomas. Journal of Personalized Medicine. 2024;14(4):401. doi:10.3390/jpm14040401

BibTeX
@article{Vogl2024,
  author = {Vogl, Thomas J and Bialek, Michael and Eichler, Katrin and Hammerstingl, Renate and Bielfeldt, John and Zangos, Stephan and Scholtz, Jan-Erik and Adwan, Hamzah},
  title = {Short- and Long-Term Outcomes after Radiofrequency Ablation of Osteoid Osteomas},
  journal = {Journal of Personalized Medicine},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {401},
  doi = {10.3390/jpm14040401}
}
Kostenlos starten →